US2010184230A1PendingUtilityA1

Nanocrystals having polynucleotide strands and their use to form dendrimers in a signal amplification system

Assignee: LIFE TECHNOLOGIES CORPPriority: Nov 10, 1998Filed: Oct 26, 2009Published: Jul 22, 2010
Est. expiryNov 10, 2018(expired)· nominal 20-yr term from priority
C12Q 1/682G01N 33/588G01N 33/54306B82Y 15/00B82Y 10/00B82Y 5/00Y10T436/143333
75
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided are compositions and assay kits comprising functionalized nanocrystals having extending therefrom a plurality of polynucleotide strands of known sequence; wherein primary dots are used to operably link to a molecular probe, and secondary dots comprise a plurality of polynucleotide strands which are complementary to the plurality of polynucleotide strands of the primary dots. Also provided is a method for detecting the presence or absence of target molecule in a sample comprising operably linking primary dots to molecular probe, contacting the complex formed with the sample, contacting the sample with successive additions of secondary dots and primary dots. If target molecule is present in the sample, the primary dots and secondary dots will form dendrimers that can be detected by fluorescence emission.

Claims

exact text as granted — not AI-modified
1 . A functionalized nanocrystal comprising a plurality of polynucleotide strands of predetermined sequence wherein a terminal portion of each of the plurality of polynucleotide strands is operably linked to the functionalized nanocrystal, and wherein the opposite terminus of each of the plurality polynucleotide strand is unbound to the functionalized nanocrystal and extends outwardly from the functionalized nanocrystal. 
     
     
         2 . The functionalized nanocrystal according to  claim 1 , wherein reactive functionalities are used to operably link the plurality of polynucleotide strands to the functionalized nanocrystal. 
     
     
         3 . The functionalized nanocrystal according to  claim 2 , wherein the functionalized nanocrystal comprises reactive functionalities, and wherein a reactive functionality of the reactive functionalities is selected from the group consisting of an amino group, a carboxyl group, thiol-reactive group, and a combination thereof. 
     
     
         4 . The functionalized nanocrystal according to  claim 2 , wherein each polynucleotide strand of the plurality of polynucleotide strand comprises a reactive functionality selected from the group consisting of an amino-reactive group, a carboxyl-reactive group, and a thiol group. 
     
     
         5 . The functionalized nanocrystal according to  claim 1 , wherein a linker is used to operably link a polynucleotide strand of the plurality of polynucleotide strands to the functionalized nanocrystal. 
     
     
         6 . The functionalized nanocrystal according to  claim 5 , wherein the functionalized nanocrystal further comprises linker comprising avidin, wherein each polynucleotide strand of the plurality of polynucleotide strands further comprises biotin, and wherein the biotin is bound to the avidin. 
     
     
         7 . The functionalized nanocrystal according to  claim 1 , wherein the functionalized nanocrystal comprises a semiconductor nanocrystal. 
     
     
         8 . The functionalized nanocrystal according to  claim 1 , wherein the functionalized nanocrystal comprises a doped metal oxide nanocrystal. 
     
     
         9 . The functionalized nanocrystal according to  claim 1 , further comprising molecular probe operably linked to the functionalized nanocrystal. 
     
     
         10 . The functionalized nanocrystal according to  claim 9 , wherein molecular probe and the functionalized nanocrystal are operably linked using means selected from the group consisting of by a reactive functionality on one or more of the plurality of polynucleotide strands and a reactive functionality associated with the molecular probe, by a reactive functionality on the coating of the functionalized nanocrystal and a reactive functionality associated with the molecular probe, by a linker which has one portion that binds to a reactive functionality on one or more polynucleotide strands and another portion which binds to a reactive functionality associated with the molecular probe, by a linker which has one portion that hybridizes to one or more polynucleotide strands and another portion which hybridizes to the molecular probe comprising a nucleic acid molecule, and by synthesizing the molecular probe as part of one or more polynucleotide strands. 
     
     
         11 . The functionalized nanocrystal according to  claim 9 , wherein molecular probe and the functionalized nanocrystal are operably linked, wherein the functionalized nanocrystal further comprises avidin, wherein molecular probe further comprises biotin, and wherein the biotin is bound to the avidin. 
     
     
         12 . A plurality of functionalized nanocrystals comprised of a functionalized nanocrystal according to  claim 1 , wherein a first species, primary dots, of the plurality of functionalized nanocrystals comprises a plurality of polynucleotide strands of a predetermined sequence; and a second species, secondary dots, of the plurality of functionalized nanocrystals comprises a plurality of polynucleotide strands of a sequence complementary to the sequence of the plurality of polynucleotide strands of the primary dot. 
     
     
         13 . A plurality of functionalized nanocrystals comprised of a functionalized nanocrystal according to  claim 9 , wherein a first species, primary dots, of the plurality of functionalized nanocrystals comprises a plurality of polynucleotide strands of predetermined sequence; and a second species, secondary dots, of the plurality of functionalized nanocrystals comprises a plurality of polynucleotide strands of a sequence complementary to the sequence of the plurality of polynucleotide strands of the primary dot. 
     
     
         14 . The functionalized nanocrystal according to  claim 3 , wherein the primary dots and secondary dots are of a uniform size. 
     
     
         15 . The functionalized nanocrystals according to  claim 12 , wherein polynucleotide strands of the plurality of polynucleotide strands of the primary dots are hybridized to polynucleotide strands of the plurality of polynucleotide strands of the secondary dots. 
     
     
         16 . The functionalized nanocrystals according to  claim 13 , wherein polynucleotide strands of the plurality of polynucleotide strands of the primary dots are hybridized to polynucleotide strands of the plurality of polynucleotide strands of the secondary dots.

Join the waitlist — get patent alerts

Track US2010184230A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.